Trial intelligence / Profile preview

Topical Tranexamic Acid With Flap Fixation in Modified Radical Mastectomy

NCT07434453Completed

Sponsor
Noorulain Pharmaceuticals
Start
Aug 2023
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tranexamic acid in Seroma and surgical site infection (SSI) (2 arms), sponsored by Noorulain Pharmaceuticals. Primary endpoint: Total Postoperative Drain Output. Started Aug 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Seromasurgical site infection (SSI)

Beyond the preview

Go deeper on NCT07434453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07434453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call